info icon

This is a non-core endpoint: only basic statistics are computed.

Bradycardia, unspecified, drug-induced

BRADY_UNSPE

Endpoint definition

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

557745

1. Apply sex-specific rule

None

557745

2. Check conditions

None

557745

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ATC codes for adverse effects of Drugs ANY
  • Hospital discharge: ICD-10 R00.1#

1 out of 7 registries used, show all original rules.

114

4. Check minimum number of events

None

114

5. Include endpoints

None

114

6. Filter based on genotype QC (FinnGen only)

98

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
C
First used in FinnGen datafreeze
DF5

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 98 45 53
Unadjusted period prevalence (%) 0.02 0.02 0.02
Median age at first event (years) 62.80 60.22 64.99

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
101
Matched controls
1010
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R00.1
ICD-10 Finland
Bradycardia, unspecified
+∞
126.3
101
16
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
9.3
19.3
27
38
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
6.8
14.9
28
54
I49.5
ICD-10 Finland
Sick sinus syndrome
7.5
13.1
21
34
FPE30
NOMESCO Finland
Replacement of transvenous cardiac pacemaker pulse generator
15.4
10.6
17
13
73
HP
Initial pacemaker installation
61.0
9.9
11
*
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
9.3
9.7
20
26
XF404
NOMESCO Finland
Ambulatory ECG
5.1
8.9
21
49
XFP02, ,
NOMESCO Finland
+∞
6.3
6
*

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
23
126
2.07
2.21
4.0
3.1
2.43
1.95
e6/l
0.15
15
58
26
155
1.91
1.98
2.1
2.6
12.42
12.26
umol/l
0.04
26
146
38
260
1.74
1.85
3.6
3.9
2.39
2.34
mmol/l
1.72
32
240
7
28
2.61
1.48
2.9
2.6
—
—
—
0
0
5
16
3.23
1.45
1.0
1.2
—
—
—
0
0
9
40
2.37
1.44
1.1
1.1
—
—
—
0
0
5
17
3.04
1.37
1.8
3.2
6.90
14.31
pmol/l
—
5
17
36
260
1.60
1.37
3.4
4.7
—
—
—
0
0
0
39
0.00
1.37
0.0
2.8
—
—
—
0
0
28
192
1.63
1.31
4.9
3.7
—
—
—
0
0
17
101
1.82
1.30
3.2
7.1
7.43
7.41
ph
—
8
63
0
33
0.00
1.18
0.0
2.1
—
0.00
—
0
9
31
231
1.49
1.00
4.6
3.3
0.28
0.65
e6/l
1.09
24
172
0
30
0.00
0.99
0.0
2.3
—
159.90
—
0
10
12
71
1.78
0.93
3.0
8.4
—
—
—
0
0
0
24
0.00
0.80
0.0
4.1
—
2.88
—
0
12
0
24
0.00
0.80
0.0
4.1
—
4.98
—
0
24
0
24
0.00
0.80
0.0
4.1
—
8.03
—
0
24
0
26
0.00
0.79
0.0
5.2
—
7.42
—
0
26
5
24
2.14
0.75
17.0
4.6
—
—
—
0
0
47
396
1.35
0.73
23.7
17.6
1.48
1.36
inr
0.62
40
330
17
120
1.50
0.70
4.6
7.0
104.18
104.02
mmol/l
0.03
17
120
24
182
1.42
0.70
4.5
2.9
621.68
527.58
mosm/kgh2o
0.87
19
161
10
153
0.62
0.69
1.3
1.3
—
—
—
0
0
41
341
1.34
0.69
2.4
2.5
86.34
91.63
pmol/l
0.27
25
184
5
30
1.70
0.62
1.4
1.2
—
—
—
0
0
30
242
1.34
0.61
2.6
2.2
—
—
—
0
0
34
280
1.32
0.60
4.7
3.5
26.78
291.63
e6/l
0.60
28
214
18
236
0.71
0.60
3.6
4.0
7.16
8.80
mg/mmol
0.17
11
157
32
262
1.32
0.59
3.0
4.8
7.40
7.40
ph
0.50
22
187
16
117
1.44
0.56
2.3
1.7
—
—
—
0
0
38
322
1.29
0.54
2.6
2.6
—
—
estimate
—
0
0
46
402
1.26
0.51
5.1
7.4
1.21
1.21
mmol/l
0.38
40
345
21
262
0.75
0.51
5.1
4.3
—
—
—
0
0
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
0
16
0.00
0.41
0.0
1.5
—
—
—
0
0
0
16
0.00
0.41
0.0
1.5
—
—
—
0
0
0
16
0.00
0.41
0.0
1.5
—
—
—
0
0
0
16
0.00
0.41
0.0
2.9
—
31.69
—
0
16
0
16
0.00
0.41
0.0
1.5
—
—
—
0
0
54
489
1.22
0.41
4.9
4.2
14.96
15.04
pmol/l
0.08
46
426
65
600
1.23
0.41
5.8
5.4
2.04
2.00
mu/l
0.08
58
524
30
255
1.25
0.41
5.3
3.8
—
—
—
0
0
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
0
17
0.00
0.41
0.0
1.3
—
—
—
0
0
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
0
18
0.00
0.40
0.0
2.2
—
1.97
—
0
18
32
275
1.24
0.40
5.5
4.7
0.00
0.03
estimate
—
5
69
9
69
1.33
0.38
1.3
2.8
—
—
—
0
0
9
70
1.31
0.38
2.6
2.2
158.67
214.58
ug/g
—
9
58
11
82
1.38
0.36
1.5
2.9
64.17
66.07
g/l
0.41
11
77
13
100
1.34
0.35
3.0
3.7
7.38
7.38
ph
—
7
61
13
101
1.33
0.33
1.3
1.3
14.00
45.69
iu/ml
—
5
34
11
83
1.37
0.33
1.4
1.7
—
—
—
0
0
7
52
1.37
0.32
4.3
10.1
95.56
94.04
%
—
7
52
41
369
1.19
0.31
5.2
4.6
0.00
0.00
estimate
—
6
84
18
149
1.25
0.30
3.4
5.3
1.02
1.02
kg/l
0.03
13
98
15
123
1.26
0.27
1.6
1.4
2.00
2.47
g/l
—
6
72
41
373
1.17
0.27
5.2
4.6
0.00
18.45
estimate
—
6
88
11
87
1.30
0.25
1.3
1.4
—
—
—
0
0
6
82
0.71
0.25
1.5
1.8
406.33
389.24
nmol/l
—
6
75
12
146
0.80
0.24
1.9
2.8
0.80
0.81
mmol/l
0.11
12
135
5
38
1.33
0.23
1.4
1.2
—
—
—
0
0
33
363
0.86
0.23
4.7
6.4
0.05
0.04
e9/l
0.79
24
306
34
308
1.16
0.23
5.6
4.2
203.01
85.31
e6/l
0.28
29
220
5
39
1.30
0.23
1.2
1.3
—
—
—
0
0
10
124
0.79
0.23
1.8
5.7
0.94
1.03
mmol/l
—
10
114
25
222
1.17
0.22
4.2
7.3
—
—
—
0
0
33
300
1.15
0.21
4.8
4.1
6.03
6.17
ph
0.38
19
158
0
10
0.00
0.21
0.0
5.4
—
—
—
0
0
58
548
1.14
0.21
8.6
8.7
75.04
82.48
u/l
0.82
51
517
0
12
0.00
0.21
0.0
2.6
—
90.69
—
0
12
41
379
1.14
0.21
5.2
4.7
0.00
0.00
estimate
—
6
81
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
0
13
0.00
0.21
0.0
1.8
—
9.15
—
0
13
0
13
0.00
0.21
0.0
2.2
—
1.87
—
0
6
0
14
0.00
0.20
0.0
2.8
—
—
—
0
0
7
59
1.20
0.18
1.3
1.5
—
—
—
0
0
43
402
1.12
0.18
6.7
9.9
4.50
4.47
e9/l
0.02
35
346
5
68
0.72
0.17
1.0
1.3
—
—
—
0
0
17
152
1.14
0.13
2.9
3.1
1.26
0.93
ug/l
—
9
110
34
361
0.91
0.12
4.6
6.3
0.57
0.63
e9/l
0.67
25
306
64
620
1.09
0.11
4.7
5.5
5.91
6.05
mmol/l
0.47
56
553
68
698
0.92
0.10
37.0
30.1
6.40
6.97
e9/l
1.91
68
675
68
698
0.92
0.10
37.6
30.6
38.63
39.17
%
0.30
68
685
68
698
0.92
0.10
37.1
30.1
226.85
243.39
e9/l
1.23
68
682
68
698
0.92
0.10
37.3
30.3
129.06
130.87
g/l
0.46
68
685
6
55
1.10
0.09
2.2
4.1
—
—
—
0
0
7
64
1.10
0.08
1.4
1.5
—
—
—
0
0
35
366
0.93
0.08
4.5
6.5
1.63
1.69
e9/l
0.16
29
320
6
73
0.81
0.08
1.2
1.4
—
—
—
0
0
9
83
1.09
0.07
1.6
1.7
—
—
—
0
0
20
212
0.93
0.06
3.0
4.6
0.00
0.00
estimate
—
5
75
10
90
1.12
0.05
1.1
1.3
—
—
—
0
0
12
110
1.10
0.05
1.6
1.3
—
—
—
0
0
28
270
1.05
0.03
2.1
2.3
—
—
—
0
0
67
661
1.04
0.02
23.1
17.8
—
—
—
0
0
36
369
0.96
0.02
4.5
6.7
0.20
0.20
e9/l
0.04
29
316
26
252
1.04
0.02
1.9
2.0
1.36
1.33
mmol/l
0.07
21
207
68
688
0.96
0.02
33.6
27.0
80.90
85.26
umol/l
0.69
68
674
62
628
0.97
0.02
6.1
6.0
2.64
2.49
mmol/l
0.55
57
562
68
678
1.01
0.00
31.0
24.8
3.94
4.01
mmol/l
1.53
68
660
68
679
1.00
0.00
31.0
24.7
139.87
139.51
mmol/l
0.49
68
663
26
263
0.98
0.00
3.7
5.8
—
—
—
0
0
31
313
0.99
0.00
15.9
14.2
0.00
0.00
e9/l
0.50
21
252
14
135
1.04
0.00
4.7
6.4
—
—
—
0
0
35
346
1.02
0.00
6.4
4.8
26.20
48.67
ng/l
1.92
25
275
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
3.1
—
—
—
0
0
6
61
0.98
0.00
3.0
4.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
0.00
0.0
1.7
—
-0.39
—
0
9
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
7.8
—
13.10
—
0
8
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
5
50
1.00
-0.00
1.6
1.9
10.90
12.04
nmol/l
—
5
44
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.0
—
41.06
—
0
7
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
12.80
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
6.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
35.67
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
1698.33
—
0
6
7
77
0.90
-0.00
1.4
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
84.20
—
0
5
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
56
0.89
-0.00
4.2
6.5
23.20
24.47
mmol/l
—
5
56
6
65
0.92
-0.00
4.5
4.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
140.20
—
0
5

Mortality – FinRegistry

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

Index endpoint: BRADY_UNSPE – Bradycardia, unspecified, drug-induced

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).